| Date | Title | Description | Source |
| 16.04.2024 | Counterfeit Botox blamed in 9-state outbreak of botulism-lik... | Biden administration investigating counterfeit botox injections in Florida, eight other states
Biden... | cbsnews.co... |
| 12.04.2024 | Botox shots, possibly counterfeit, linked to botulism-like i... | Doctors warn about popular cosmetic procedure called Barbie Botox
Doctors warn about popular cosmeti... | cbsnews.co... |
| 11.04.2024 | AbbVie’s AQUIPTA[®]▼(atogepant) Is Recommended By NICE For T... | AbbVie’s AQUIPTA[®]▼(atogepant) Is Recommended By NICE For The Prevention Of Migraine In Adults
Thu,... | news.cisio... |
| 25.03.2024 | AbbVie Gets Another Ulcerative Colitis Contender via $137M L... | AbbVie already has blockbuster drugs for ulcerative colitis, but that isn’t stopping the pharmaceuti... | medcitynew... |
| 21.03.2024 | Advances in Digitalization Presented at the 10th Annual Gene... | Digitalizing Biopharma R&D: The Genedata Biopharma Platform is the #1 enterprise software system... | prweb.com/... |
| 17.03.2024 | AbbVie Expands Biologics Manufacturing Capacity with a $223 ... | US$223 million expansion will add biologics capacity to AbbVie manufacturing network
Singapore manuf... | einpresswi... |
| 17.03.2024 | A long-time bull who predicted this market rally warns that ... | Markets A long-time bull who predicted this market rally warns that gains are unsustainable — but th... | businessin... |
| 15.03.2024 | World Sleep Day Sees Launch of Parkinson’s Disease SLEEP Sur... | Insomnia, restless legs syndrome, and REM sleep behavior disorder are just a few issues people livin... | einpresswi... |
| 13.03.2024 | Contraceptives Market Growth Soars: Aiming for $50.6 Billion... | Contraceptives Market Report
WILMINGTON, DELAWARE, UNITED STATES, March 13, 2024 /EINPresswire.com/ ... | einpresswi... |
| 13.03.2024 | Coherus BioSciences Reports Fourth Quarter, Full Year 2023 F... | – Net revenue of $91.5 million in the fourth quarter and $257.2 million in FY 2023 – – UDENYCA® net ... | einpresswi... |
| 13.03.2024 | После вмешательства генпрокурора РФ 68 южноуральцев обеспече... | - | kommersant... |
| 12.03.2024 | Tellius Reveals GenAI Enhancements, Pioneering Enterprise An... | Tellius, theAI-native analytics company, unveiled a groundbreaking expansion of its generative AI (G... | aithority.... |
| 11.03.2024 | Contract Research And Manufacturing Services (CRAMS) Market ... | Contract Research And Manufacturing Services (CRAMS) Global Market Report 2024 – Market Size, Trends... | einpresswi... |
| 11.03.2024 | AbbVie’s Produodopa® (foslevodopa-foscarbidopa) Accepted by ... | AbbVie’s Produodopa® (foslevodopa-foscarbidopa) Accepted by Scottish Medicines Consortium as Treatme... | news.cisio... |
| 11.03.2024 | Nitrase Therapeutics Unveils Pioneering Antibody Candidate f... | -Nitrase’s first-in-class antibody found to significantly delay progression of Parkinson’s disease i... | svhealthin... |
| 08.03.2024 | Peptide Therapeutics Market Size, Share, Revenue, Trends And... | Peptide Therapeutics Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
The Business R... | einpresswi... |
| 08.03.2024 | Seladelpar (MBX-8025) Market Overview and Outlook 2024-2032:... | - | globenewsw... |
| 08.03.2024 | Psychedelic Drugs Market Size, Share And Growth Analysis For... | Psychedelic Drugs Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
The... | einpresswi... |
| 08.03.2024 | Gynecology Drugs Market Size, Share And Growth Analysis For ... | Gynecology Drugs Global Market Report 2024 – Market Size, Trends, And Global Forecast 2023-2032
The ... | einpresswi... |
| 07.03.2024 | Rheumatoid Arthritis (RA) Patient Pool Analysis in APAC: Mar... | - | globenewsw... |
| 05.03.2024 | Health | The new beauty regimen: Lose weight with Ozempic, t... | Andrea Chang | Los Angeles Times (TNS)
LOS ANGELES — Jeniffer Brown wanted the Ozempic body. She jus... | dailycamer... |
| 04.03.2024 | Pharmaceutical Manufacturing Market Projected to Grow at 7.8... | Vantage Market Research
Pharmaceutical Manufacturing Market Size, Share, Industry Trends, Growth, an... | einpresswi... |
| 04.03.2024 | Biopharmaceutical Innovations Lead the Way in Migraine Drugs... | Migraine is a clinical condition associated with painful headaches and other symptoms such as nausea... | einpresswi... |
| 01.02.2024 | NICE Recommends Subcutaneous Treatment Option Tepkinly[®]▼(e... | NICE Recommends Subcutaneous Treatment Option Tepkinly[®]▼(epcoritamab) for Eligible* Adults with Ag... | news.cisio... |
| 26.01.2024 | AbbVie Expands Biologics Manufacturing Capacity with a $223 ... | US$223 million expansion will add biologics capacity to AbbVie manufacturing network
Singapore manuf... | en.prnasia... |
| 06.12.2023 | AbbVie and BigHat Biosciences Announce Research Collaboratio... | Collaboration to leverage BigHat’s Artificial Intelligence and Machine Learning (AI/ML) guided Milli... | aithority.... |
| 30.11.2023 | AbbVie Acquires ImmunoGen, for Approx. $10.1 Billion | AbbVie (NYSE: ABBV) acquired ImmunoGen (NASDAQ: IMGN), a Waltham, MA-based company developing antibo... | finsmes.co... |
| 01.11.2023 | いい歳をとりたい女性の「しわ・たるみ」の悩みに正しい知識を『いい歳とり隊』サポート強化月間 始動... | 加齢とともに肌悩みは変化し、スキンケアでは解決できない「しわ・たるみ」の肌悩みが気になる方も多いのではないでしょうか。「女性の顔の肌悩み（2023）」調査（*1）によると40代から「しわ・たるみ」がT... | prtimes.jp... |
| 24.10.2023 | MHRA Grants Conditional Marketing Authorisation for Tepkinly... | MHRA Grants Conditional Marketing Authorisation for Tepkinly[®]▼(epcoritamab) as a Bispecific Treatm... | news.cisio... |
| 09.10.2023 | AbbVie’s AQUIPTA[®]▼ (atogepant) Is Now Available In Scotlan... | AbbVie’s AQUIPTA[®]▼ (atogepant) Is Now Available In Scotland For The Prevention Of Migraines In Adu... | news.cisio... |
| 04.09.2023 | AbbVie’s AQUIPTA[®]▼(atogepant) receives MHRA marketing auth... | AbbVie’s AQUIPTA[®]▼(atogepant) receives MHRA marketing authorisation for the prevention of migraine... | news.cisio... |
| 13.08.2023 | Excellence In Science And Math Runs In The Family | The Geneus Family in Cap and Gown at Olivia Geneus's PhD graduation from SUNY at Buffalo.Photo Credi... | forbes.com... |
| 12.06.2023 | SMC Accepts RINVOQ[®]▼ (upadacitinib) as a Treatment Option ... | SMC Accepts RINVOQ[®]▼ (upadacitinib) as a Treatment Option for Adults with Moderately to Severely A... | news.cisio... |
| 18.05.2023 | NICE Recommends RINVOQ[®]▼(upadacitinib) as a Treatment Opti... | NICE Recommends RINVOQ[®]▼(upadacitinib) as a Treatment Option for Moderately to Severely Active Cro... | news.cisio... |
| 13.02.2023 | Despite Retro Name, Health Datapalooza Looks Ahead To Patien... | Health Datapalooza, organized by AcademyHealth, focuses on digital health innovations impacting ... ... | forbes.com... |
| 01.02.2023 | MHRA Approves RINVOQ[®]▼ (upadacitinib) as First Oral Advanc... | MHRA Approves RINVOQ[®]▼ (upadacitinib) as First Oral Advanced Therapy to Treat Adults with Moderate... | news.cisio... |
| 12.12.2022 | Scottish Medicines Consortium (SMC) Extends Advice Accepting... | Scottish Medicines Consortium (SMC) Extends Advice Accepting RINVOQ®▼(upadacitinib) For Treatment of... | news.cisio... |
| 25.11.2022 | NICE recommends RINVOQ[®]▼ (upadacitinib) As Treatment Optio... | NICE recommends RINVOQ[®]▼ (upadacitinib) As Treatment Option For Moderately to Severely Active Ulce... | news.cisio... |
| 12.10.2022 | Allergan Aesthetics Pledges Diamond Level Sponsorship for 20... | ARLINGTON HEIGHTS, Ill. (PRWEB) October 12, 2022
The American Society of Plastic Surgeons (ASPS), th... | prweb.com/... |
| 17.08.2022 | NICE Recommends RINVOQ[®]▼(upadacitinib) As A Treatment Opti... | NICE Recommends RINVOQ[®]▼(upadacitinib) As A Treatment Option For Active Ankylosing Spondylitis (AS... | news.cisio... |
| 17.08.2022 | Global Dermal Fillers Market Vendor Landscape and Geographic... | Dermal Fillers
Global Dermal Fillers market size is estimated to be USD 8.74 billion in 2029 from US... | einpresswi... |
| 11.08.2022 | NICE Recommendation Expands Patient Eligibility for AbbVie’s... | NICE Recommendation Expands Patient Eligibility for AbbVie’s Ozurdex[® ](dexamethasone 0.7mg intravi... | news.cisio... |
| 26.07.2022 | MHRA Approves RINVOQ®▼ (upadacitinib) For the Treatment of M... | MHRA Approves RINVOQ®▼ (upadacitinib) For the Treatment of Moderately to Severely Active Ulcerative ... | news.cisio... |
| 26.07.2022 | MHRA Approves RINVOQ®▼ (upadacitinib) For the Treatment of M... | MHRA Approves RINVOQ®▼ (upadacitinib) For the Treatment of Moderately to Severely Active Ulcerative ... | news.cisio... |
| 13.07.2022 | AbbVie Employees in Asia Volunteer in Annual Week of Possibi... | Employees in Asia joined the global efforts to make a difference in local communities.
Employees acr... | en.prnasia... |
| 29.06.2022 | NICE recommends AbbVie’s RINVOQ[®▼ (upadacitinib) for use in... | NICE recommends AbbVie’s RINVOQ[®▼ (upadacitinib) for use in adults and adolescents 12 years and old... | news.cisio... |
| 09.05.2022 | Scottish Medicines Consortium Accepts Chemotherapy-free Comb... | Scottish Medicines Consortium Accepts Chemotherapy-free Combination Treatment VENCLYXTO[®]▼(Venetocl... | news.cisio... |
| 19.04.2022 | People with Moderate to Severe Uncontrolled Crohn’s Disease ... | People with Moderate to Severe Uncontrolled Crohn’s Disease Granted Early Access to New Investigatio... | news.cisio... |
| 11.04.2022 | Scottish Medicines Consortium Accepts VENCLYXTO[®]▼(venetocl... | Scottish Medicines Consortium Accepts VENCLYXTO[®]▼(venetoclax) Combination in Patients with the Agg... | news.cisio... |
| 11.04.2022 | Scottish Medicines Consortium accepts AbbVie’s RINVOQ[®▼] (u... | Scottish Medicines Consortium accepts AbbVie’s RINVOQ[®▼] (upadacitinib) for Use in Adolescents and ... | news.cisio... |
| 18.03.2022 | Botox maker AbbVie suspends operations in Russia | Russians will have to cope without their Botox — an injectable drug that smooths wrinkles — as long ... | cbsnews.co... |
| 06.03.2022 | AbbVie Completes Acquisition of Syndesi Therapeutics, for Up... | AbbVie (NYSE: ABBV) completed the acquisition of Syndesi Therapeutics SA, a Belgium-based clinical s... | finsmes.co... |
| 01.02.2022 | AbbVie Showcases Its Leadership in Research in Inflammatory ... | NORTH CHICAGO, Ill., Feb. 1, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will present further analyses ... | marketscre... |
| 11.01.2022 | NICE recommends AbbVie’s RINVOQ[® ▼ (upadacitinib) ]For Use ... | NICE recommends AbbVie’s RINVOQ[® ▼ (upadacitinib) ]For Use in Adults with Active Psoriatic Arthriti... | news.cisio... |
| 30.11.2021 | AbbVie Submits Application for Risankizumab (SKYRIZI®) in Mo... | NORTH CHICAGO, Ill., Nov. 30, 2021 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced it has submitt... | marketscre... |
| 29.10.2021 | AbbVie Reports Third-Quarter 2021 Financial Results | NORTH CHICAGO, Ill., Oct. 29, 2021 /PRNewswire/ -- AbbVie (NYSE:ABBV) announced financial results fo... | marketscre... |
| 19.10.2021 | Is This The Most Exciting Medical Breakthrough Of The Decade | FN Media Group Presents Oilprice.com Market Commentary
LONDON, Oct. 19, 2021 /PRNewswire/ -- Accordi... | salamancap... |
| 19.10.2021 | Is This The Most Exciting Medical Breakthrough Of The Decade | LONDON, Oct. 19, 2021 /PRNewswire/ -- According to Google's Health boss David Feinberg... over one b... | salamancap... |
| 07.10.2021 | NICE issues positive Final Appraisal Document for AbbVie’s R... | NICE issues positive Final Appraisal Document for AbbVie’s RINVOQ[®]▼(upadacitinib) in moderate acti... | news.cisio... |
| 06.10.2021 | AbbVie Presents Late-Breaking Data on Risankizumab (SKYRIZI[... | AbbVie Presents Late-Breaking Data on Risankizumab (SKYRIZI[®])▼ in Psoriatic Arthritis at the 30th ... | news.cisio... |
| 03.10.2021 | AbbVie : to Showcase New Data at the United European Gastroe... | NORTH CHICAGO, Ill., Oct. 2, 2021 /PRNewswire/ -- AbbVie today announced new data on the investigati... | marketscre... |
| 30.09.2021 | AbbVie : Presents New Analyses Evaluating RINVOQ® (upadaciti... | NORTH CHICAGO, Ill., Sept. 30, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new analyses... | marketscre... |
| 23.09.2021 | AbbVie : Presents New Data Analyses for Growing Dermatology ... | NORTH CHICAGO, Ill., Sept. 23, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it will pres... | marketscre... |
| 06.09.2021 | 10 Unique and Creative Ways Businesses Are Recruiting Right ... | September 6, 2021 5 min read This story originally appeared on CO— by the U.S. Chamber of Commerce
T... | entreprene... |
| 24.08.2021 | AbbVie : European Commission Approves RINVOQ® (upadacitinib)... | NORTH CHICAGO, Ill., Aug. 24, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the European ... | marketscre... |
| 12.08.2021 | AbbVie : Ventures Launches Inaugural AIM Award | AbbVie Ventures is excited to announce the launch of its inaugural AbbVie Innovation Midwest (AIM) A... | marketscre... |
| 10.08.2021 | Reps. Cheri Bustos, Steve Chabot, and August Pfluger have br... | Reps. Steve Chabot, a Republican from Ohio; Cheri Bustos, a Democrat from Illinois; and August Pflug... | businessin... |
| 09.08.2021 | Mission and AbbVie collaboration in Alzheimer’s and Parkinso... | Mission and AbbVie collaboration in Alzheimer’s and Parkinson’s diseases reaches next milestone
09-0... | cambridgen... |
| 04.08.2021 | JAMA Dermatology Publishes Data Showing Upadacitinib Achieve... | JAMA Dermatology Publishes Data Showing Upadacitinib Achieved Superiority vs Dupilumab for Primary a... | news.cisio... |
| 04.08.2021 | AbbVie : JAMA Dermatology Publishes Data Showing RINVOQ® (up... | NORTH CHICAGO, Ill., Aug. 4, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that JAMA Derm... | marketscre... |
| 28.06.2021 | AbbVie : Gastroenterology Pipeline to be Featured at the 16t... | NORTH CHICAGO, Ill., June 28, 2021 /PRNewswire/ -- AbbVie today announced new data on upadacitinib (... | marketscre... |
| 04.06.2021 | New SKYRIZI [® ][]▼ (risankizumab) 150 mg Presentation Pre-f... | New SKYRIZI [® ][]▼ (risankizumab) 150 mg Presentation Pre-filled Pen and Pre-filled Syringe Approve... | news.cisio... |
| 03.06.2021 | New Long-Term Efficacy and Safety Analyses Evaluating RINVOQ... | New Long-Term Efficacy and Safety Analyses Evaluating RINVOQ[®] ▼ (upadacitinib) in Patients with Rh... | news.cisio... |
| 24.05.2021 | The Lancet Publishes Results from Pivotal Global Phase 3 Pro... | The Lancet Publishes Results from Pivotal Global Phase 3 Programme Evaluating RINVOQ[®] (upadacitini... | news.cisio... |
| 29.04.2021 | AbbVie Remains One of the Best Buys in Its Sector | April 29, 2021 4 min read This story originally appeared on MarketBeat
AbbVie (NYSE:ABBV) will be am... | entreprene... |
| 24.04.2021 | Model, Reality TV Personality, and Actress Cynthia Bailey-Hi... | Ms. Bailey-Hill has been an outspoken advocate for greater education and access to care for women wi... | prweb.com/... |
| 01.04.2021 | SkinMedica® Launches Neck Correct Cream for Neck and Décolle... | | prnewswire... |
| 22.02.2021 | AbbVie : Second Phase 3 Induction Study Confirms Upadacitini... | NORTH CHICAGO, Ill., Feb. 22, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that upadacit... | marketscre... |
| 26.01.2021 | CoolSculpting® by Allergan Aesthetics Expands Body Contourin... | | prnewswire... |
| 18.11.2020 | The Most Common Symptom of Uterine Fibroids? Heavy Menstrual... | (BPT) - Most women learn how to manage their periods beginning in their teenage years, often jugglin... | salamancap... |
| 11.09.2020 | A year out from FDA approval, Vertex looks to expand top-... | About a year after getting the FDA thumbs-up for its blockbuster cystic fibrosis drug Trikaft... | endpts.com... |
| 10.09.2020 | Orasis Pharmaceuticals snags $30M to see its presbyop... | Orasis Pharmaceuticals is one of several biotechs developing miotic-based eye drops as a ... | endpts.com... |
| 15.07.2019 | AbbVie Acquires Mavupharma | AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company, acquired Ma... | finsmes.co... |
| 25.06.2019 | AbbVie to Acquire Allergan for Approx. $63 Billion | Biopharma giant AbbVie Inc. (NYSE: ABBV) is to acquire Allergan plc (NYSE: AGN), a Dublin, Ireland-b... | finsmes.co... |
| 27.11.2018 | DDF notes Rheostat $23 Million Series A Financing | The Dementia Discovery Fund notes that Rheostat, a biotech company focused on the discovery of novel... | svhealthin... |
| 26.11.2018 | Rheostat Therapeutics Raises $23M Series A | CAMBRIDGE, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Rheostat Therapeutics, a biotech company focused... | citybizlis... |
| 30.04.2016 | M&A roundup - week ending 4/30/16 | Rovi bought TiVo for $1.1B; Comcast bought DreamWorks for $3.8B; AbbVie bought Stemcentrx for $5.8B
... | vator.tv/n... |
| 29.04.2016 | AbbVie to Acquire Stemcentrx, for up to $9.8 Billion | AbbVie (NYSE:ABBV), a Chicago,Illinois-based global biopharmaceutical company, is to acquire South S... | finsmes.co... |
| 28.04.2016 | AbbVie acquiring cancer drug startup StemcenTrx for $5.8 bil... | Drug research giant AbbVie announced a deal to buy cancer drug startup Stemcentrx in a $5.8 billion ... | techcrunch... |
| 11.01.2016 | Daily funding roundup - January 11, 2016 | Cardiorentis secured $60M; BioAlta raised $45M; V-Wave completed $28M funding
Wamda Capital, A Dubai... | vator.tv/n... |
| 25.09.2015 | Former Pharmacyclics CEO raises $75M Series B for new immuno... | This new round, ostensibly a Series B, has 33 investors participating. The company has yet to return... | medcitynew... |
| 04.09.2014 | AbbVie Reveals Commitment to Innovation Economy Through $1.5... | Last week, Bob Nelsen, the co-founder and managing director at Arch Ventures - a leading VC firm in ... | bizjournal... |
| 03.09.2014 | Google-backed Calico and Abbott Labs spinoff will build anti... | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
| 03.09.2014 | Google-backed Calico and Abbott Labs spinoff will build anti... | The Google-backed health science company Calico has announced an agreement with the biotech firm Abb... | venturebea... |
| 05.08.2013 | AbbVie, angel investors restock nanomedicine leader Chad Mir... | The startup is developing a platform for nucleic acid-based therapeutics with applications in oncolo... | medcitynew... |
| - | Hacker Games Record: 300 Participants, 49 Projects, 12 Winne... | A new set of innovative product-ideas was set afloat over the weekend! The 11th hackathon of the ann... | startuplit... |
| - | Healthcare corporations Pfizer and UnitedHealthcare are amon... | Eugenio Marongiu/Getty Images; Jenny Chang-Rodriguez/Getty Images
Healthcare companies funded lawmak... | businessin... |
| - | AbbVie, angel investors restock nanomedicine leader Chad Mir... | For a Northwestern University biopharmaceutical spinoff, a second tranche of series B funding will p... | medcitynew... |
| - | Health track – introducing the newest addition to Hacker Gam... | The staple hackathon series in Lithuania is starting the year with some new arrangements. Hacker Gam... | startuplit... |
| - | Former Pharmacyclics CEO raises $75M Series B for new immuno... | Bay area immuno-oncology startup Corvus Pharmaceuticals just raised an impressive $75 million, SEC f... | medcitynew... |
